tirzepatide decision Judge says compounding pharmacies must stop making copies of Zepbound, Mounjaro Tirzepatide Dosage Chart & Dosing

Weight loss is known to trigger compensatory biology: Increased appetite signaling Reduced resting energy expenditure Heightened food reward sensitivity Stopping GLP-1 therapy at peak dose, without tapering and without reinforcing lifestyle strategies at the exact moment hunger returns, does not allow lifestyle behaviors to take over. Emerging real-world data and obesity physiology suggest a different, more clinically relevant path: Gradual dose reduction rather than abrupt cessation Continued, structured dietary and exercise support Active monitoring during the high-risk post-cessation period We still need randomized trials designed specifically to test tapering and lifestyle-anchored maintenance strategies

We explore solutions here.

Discover why it happens, how to manage your appetite, and tips to enhance medication effectiveness for lasting healthier results.

Explore if Blue Cross Blue Shield of Illinois covers Tirzepatide, learn potential coverage obstacles, costs without insurance, and get answers to common questions.

In this episode of Black Doctors Speak, Dr